Tacrolimus Versus Intravenous Pulse Cyclophosphamide Therapy in Chinese Adults With Steroid-Resistant Idiopathic Minimal Change Nephropathy: A Multicenter, Open-Label, Nonrandomized Cohort Trial
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference35 articles.
1. Adult minimal-change disease: clinical characteristics, treatment and outcomes;Waldman;Clin J Am Soc Nephrol,2007
2. Adult-onset minimal change disease among Taiwanese: clinical features, therapeutic response, and prognosis;Huang;Am J Nephrol,2001
3. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children;Bonilla-Felix;Kidney Int,1999
4. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome;Baipai;Pediatr Nephrol,2003
5. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome—a randomized controlled multicentre trial by the Arbeitsgemeinschaft fur Padiatrische Nephrologie;Plank;Pediatr Nephrol,2008
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intravenous cyclophosphamide therapy in children with calcineurin inhibitor-resistant steroid-resistant nephrotic syndrome in a resource-limited setting;Pediatric Nephrology;2023-11-10
2. Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial;JMIR Research Protocols;2023-06-16
3. Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial (Preprint);2023-01-31
4. Primary Nephrotic Syndrome;Nephrology Self-Assessment Program;2022-12
5. Efficacy and safety of tacrolimus versus corticosteroid as initial monotherapy in adult-onset minimal change disease: a meta-analysis;International Urology and Nephrology;2022-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3